Actinium Pharmaceuticals, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
ATNM on NYSE
Industry
Pharmaceutical Preparations
Location
100 Park Ave., 23 Rd Floor, New York, NY

There are no Buy or Sell transactions made by insiders since 12/2/2024

Actinium Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sandesh Seth Chief Executive Officer, Director $315K Aug 18, 2025
Ajit Shetty Director Mar 31, 2025
Richard Steinhart Director Mar 31, 2025
Steve O'Loughlin Chief Financial Officer Mar 31, 2025
C. David Nicholson Director Mar 31, 2025
Jeffrey W. Chell Director Mar 31, 2025
June Sherie Almenoff Director Mar 31, 2025
Mark Berger Chief Medical Officer Sep 1, 2021

Recent Insider Transactions by Companies or Individuals for Actinium Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.